Health Discoveries in Lung Cancer
Daily dose of pistachio nuts could lower risk of lung cancer
December 31, 2009
Eating pistachio nuts daily could reduce the risk of lung and other cancers, according to a study presented during a recent conference of the American Association for Cancer Research.
Pistachios are a good source of gamma-tocopherol, a form of Vitamin E, which protects against some types of cancer, said Ladia Hernandez, a senior research dietitian at the University of Texas M.D. Anderson Cancer Center. They also are a heart-healthy food because they lower cholesterol, as well as provide antioxidants.
"Pistachios are one of those 'good-for-you' nuts, and 2 ounces per day could be incorporated into dietary strategies designed to reduce the risk of lung cancer without significant changes in body mass index," said Hernandez, adding that other nuts and corn oil also have a high level of gamma-tocopherol in them.
The Feinstein Institute for Medical Research has several lung cancer clinical trials under way, including one that is studying whether a combination of certain chemotherapy drugs can slow the growth of tumors in patients recently diagnosed with non-small cell lung cancer (NSCLC). The institute is the research facility of the North Shore-LIJ Health System.
Pistachios are a good source of gamma-tocopherol, a form of Vitamin E, which protects against some types of cancer, said Ladia Hernandez, a senior research dietitian at the University of Texas M.D. Anderson Cancer Center. They also are a heart-healthy food because they lower cholesterol, as well as provide antioxidants.
"Pistachios are one of those 'good-for-you' nuts, and 2 ounces per day could be incorporated into dietary strategies designed to reduce the risk of lung cancer without significant changes in body mass index," said Hernandez, adding that other nuts and corn oil also have a high level of gamma-tocopherol in them.
The Feinstein Institute for Medical Research has several lung cancer clinical trials under way, including one that is studying whether a combination of certain chemotherapy drugs can slow the growth of tumors in patients recently diagnosed with non-small cell lung cancer (NSCLC). The institute is the research facility of the North Shore-LIJ Health System.